Cholera

Lancet

Volumn 363, Issue 9404, 2004, Pages 223-233

  Sack, David A ^a,b,c   Sack, R Bradley ^b   Nair, G Balakrish ^a   Siddique, A K ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CHOLERA VACCINE; GENTAMICIN; KANAMYCIN; QUINOLONE DERIVATIVE; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VACCINE; VIRULENCE FACTOR;

AFRICA; ANTIBIOTIC RESISTANCE; BLOOD GROUP TYPING; CHOLERA; CLINICAL FEATURE; CONFERENCE PAPER; DEHYDRATION; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; ENDEMIC DISEASE; HUMAN; INTESTINE INFECTION; MEDICAL RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REDUCTION; REHYDRATION; RISK FACTOR; SHOCK; SOUTH AMERICA; VACCINATION; VIBRIO CHOLERAE;

EID: 1642493765     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15328-7     Document Type: Conference Paper

References (150)

1. Barua D., Burrows W. Cholera. 1974;WB Saunders, Philadelphia.
2. Pollitzer R. Cholera. With a chapter on World incidence. 1959;WHO, Geneva.
3. Rosenberg C.E. The cholera years, the United States in 1832, 1849, and 1866. 1962;University of Chicago Press, Chicago.
4. Snow J., Frost W.H., Richardson B.W. Snow on cholera. 1936;Commonwealth Fund, New York.
5. Koch R. An address on cholera and its bacillus. BMJ. 2:1894;453-459.
6. Duffy J. The history of Asiatic cholera in the United States. Bull N Y Acad Med. 47:1971;1152-1168.
7. Barua D. The global epidemiology of cholera in recent years. Proc R Soc Med. 65:1972;423-428.
8. Tanamal S. Notes on paracholera in Sulawesi (Celebes). Am J Trop Med Hyg. 8:1959;72-78.
9. Cvjetanovic B., Barua D. The seventh pandemic of cholera. Nature. 239:1972;137-138.
10. Goodgame R.W., Greenough W.B. Cholera in Africa: a message for the West. Ann Intern Med. 82:1975;101-106.
11. Kustner H.G., Gibson I.H., Carmichael T.R., et al. The spread of cholera in South Africa. S Afr Med J. 60:1981;87-90.
12. Baine W.B., Mazzotti M., Greco D., et al. Epidemiology of cholera in Italy in 1973. Lancet. 2:1974;1370-1374.
13. Cholera in Spain. BMJ. 3:1971;266.
14. Swerdlow D.L., Mintz E.D., Rodriguez M., et al. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet. 340:1992;28-33.
15. Weil O., Berche P. The cholera epidemic in Ecuador: towards an endemic in Latin America. Rev Epidemiol Sante Publique. 40:1992;145-155.
16. Blake P.A., Allegra D.T., Snyder J.D., et al. Cholera-a possible endemic focus in the United States. N Engl J Med. 302:1980;305-309.
17. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 1993; 342: 387-390.
18. Ramamurthy T., Garg S., Sharma R., et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet. 341:1993;703-704.
19. Hisatsune K., Kondo S., Isshiki Y., Iguchi T., Kawamata Y., Shimada T. O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Biochem Biophys Res Commun. 196:1993;1309-1315.
20. Faruque S.M., Chowdhury N., Kamruzzaman M., et al. Reemergence of epidemic Vibrio cholerae Q139, Bangladesh. Emerg Infect Dis. 9:2003;1116-1122.
21. Shapiro R.L., Otieno M.R., Adcock P.M., et al. Transmission of epidemic Vibrio cholerae O1 in rural western Kenya associated with drinking water from Lake Victoria: an environmental reservoir for cholera? Am J Trop Med Hyg. 60:1999;271-276.
22. Hughes J.M., Boyce J.M., Levine R.J., et al. Epidemiology of eltor cholera in rural Bangladesh: importance of surface water in transmission. Bull World Health Organ. 60:1982;395-404.
23. Glass R.I., Claeson M., Blake P.A., Waldman R.J., Pierce N.F. Cholera in Africa: lessons on transmission and control for Latin America. Lancet. 338:1991;791-795.
24. Siddique A.K., Zaman K., Baqui A.H., et al. Cholera epidemics in Bangladesh: 1985-1991. J Diarrhoeal Dis Res. 10:1992;79-86.
25. Glass R.I., Becker S., Huq M.I., et al. Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol. 116:1982;959-970.
26. Sack R.B., Siddique A.K., Longini I.M. Jr, et al. A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis. 187:2003;96-101.
27. Tauxe R.V., Mintz E.D., Quick R.E. Epidemic cholera in the new world: translating field epidemiology into new prevention strategies. Emerg Infect Dis. 1:1995;141-146.
28. Pascual M., Rodo X., Ellner S.P., Colwell R., Bouma M.J. Cholera dynamics and El Nino-Southern Oscillation. Science. 289:2000;1766-1769.
29. Khan M., Shahidullah M. Cholera due to the E1 Tor biotype equals the classical biotype in severity and attack rates. J Trop Med Hyg. 83:1980;35-39.
30. Barua D., Paguio A.S. ABO blood groups and cholera. Ann Hum Biol. 4:1977;489-492.
31. Glass R.I., Holmgren J., Haley C.E., et al. Predisposition for cholera of individuals with O blood group: possible evolutionary significance. Am J Epidemiol. 121:1985;791-796.
32. Clemens J.D., Sack D.A., Harris J.R., et al. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J Infect Dis. 159:1989;770-773.
33. Hornick R.B., Music S.I., Wenzel R., et al. The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med. 47:1971;1181-1191.
34. Sack D.A., Tacket C.O., Cohen M.B., et al. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 66:1998;1968-1972.
35. Sack G.H. Jr, Pierce N.F., Hennessey K.N., Mitra R.C., Sack R.B., Mazumder D.N. Gastric acidity in cholera and noncholera diarrhoea. Bull World Health Organ. 47:1972;31-36.
36. Ries A.A., Vugia D.J., Beingolea L., et al. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 166:1992;1429-1433.
37. Gunnlaugsson G., Einarsdottir J., Angulo F.J., Mentambanar S.A., Passa A., Tauxe R.V. Funerals during the 1994 cholera epidemic in Guinea-Bissau, West Africa: the need for disinfection of bodies of persons dying of cholera. Epidemiol Infect. 120:1998;7-15.
38. Azurin J.C., Kobari K., Barua D., et al. A long-term carrier of cholera: cholera Dolores. Bull World Health Organ. 37:1967;745-749.
39. Global Task Force on Cholera Control. Guidelines for cholera control. 1993;WHO, Geneva.
40. Butler T., Arnold M., Islam M. Depletion of hepatic glycogen in the hypoglycaemia of fatal childhood diarrhoeal illnesses. Trans R Soc Trop Med Hyg. 83:1989;839-843.
41. Carpenter C.C. Jr, Mondal A., Sack R.B., Dans P.E., Wells S.A. Clinical studies in Asiatic cholera. Bull Johns Hopkins Hosp. 118:1966;174-196.
42. Khan P.K. Asiatic cholera in pregnancy. Int Surg. 51:1969;138-141.
43. Molla A.M., Rahman M., Sarker S.A., Sack D.A., Molla A. Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, and V cholerae in children. J Pediatr. 98:1981;835-838.
44. Molla A.M., Sarker S.A., Hossain M., Molla A., Greenough WB III. Rice-powder electrolyte solution as oral-therapy in diarrhoea due to Vibrio cholerae and Escherichia coli. Lancet. 1:1982;1317-1319.
45. Zaman K., Yunus M., Rahman A., Chowdhury H.R., Sack D.A. Efficacy of a packaged rice oral rehydration solution among children with cholera and cholera-like illness. Acta Paediatr. 90:2001;505-510.
46. Lindenbaum J., Greenough W.B., Islam M.R. Antibiotic therapy of cholera. Bull World Health Organ. 36:1967;871-883.
47. Sack D.A., Islam S., Rabbani H., Islam A. Single-dose doxycycline for cholera. Antimicrob Agents Chemother. 14:1978;462-464.
48. Kabir I., Khan W.A., Haider R., Mitra A.K., Alam A.N. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. J Diarrhoeal Dis Res. 14:1996;243-247.
49. Khan W.A., Bennish M.L., Seas C., et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139. Lancet. 348:1996;296-300.
50. Khan W.A., Saha D., Rahman A., Salam M.A., Bogaerts J., Bennish M.L. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial. Lancet. 360:2002;1722-1727.
51. Sack R.B. Prophylactic antibiotics? The individual versus the community. N Engl J Med. 300:1979;1107-1108.
52. Mhalu F.S., Mmari P.W., Ijumba J. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet. 1:1979;345-347.
53. Glass R.I., Huq I., Alim A.R., Yunus M. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis. 142:1980;939-942.
54. Sack D.A., Lyke C., McLaughlin C., Suwanvanichkij V. Antimicrobial resistance in shigellosis, cholera and campylobacteriosis. 2001;WHO, Geneva.
55. Waldor M.K., Tschape H., Mekalanos J.J. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol. 178:1996;4157-4165.
56. Hochhut B., Lotfi Y., Mazel D., Faruque S.M., Woodgate R., Waldor M.K. Molecular analysis of antibiotic resistance gene clusters in Vibrio cholerae O139 and O1 SXT constins. Antimicrob Agents Chemother. 45:2001;2991-3000.
57. Mukhopadhyay A.K., Basu I., Bhattacharya S.K., Bhattacharya M.K., Nair G.B. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India. Antimicrob Agents Chemother. 42:1998;206-207.
58. Garg P., Sinha S., Chakraborty R., et al. Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrob Agents Chemother. 45:2001;1605-1606.
59. Baranwal S., Dey K., Ramamurthy T., Nair G.B., Kundu M. Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother. 46:2002;2676-2678.
60. Recchia G.D., Hall R.M. Gene cassettes: a new class of mobile element. Microbiology. 141:1995;3015-3027.
61. Hall R.M., Collis C.M. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol. 15:1995;593-600.
62. Thungapathra M., Amita, Sinha K.K., et al. Occurrence of antibiotic resistance gene cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in class I integrons in Non-O1, Non-O139 Vibrio cholerae strains in India. Antimicrob Agents Chemother. 46:2002;2948-2955.
63. Yamai S., Okitsu T., Shimada T., Katsube Y. Distribution of serogroups of Vibrio cholerae non-O1 non-O139 with specific reference to their ability to produce cholera toxin, and addition of novel serogroups. Kansenshogaku Zasshi. 71:1997;1037-1045.
64. Morris J.G. Jr, Takeda T., Tall B.D., et al. Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest. 85:1990;697-705.
65. Dakin W.P., Howell D.J., Sutton R.G., O'Keefe M.F., Thomas P. Gastroenteritis due to non-agglutinable (non-cholera) vibrios. Med J Aust. 2:1974;487-490.
66. Aldova E., Laznickova K., Stepankova E., Lietava J. Isolation of nonagglutinable vibrios from an enteritis outbreak in Czechoslovakia. J Infect Dis. 118:1968;25-31.
67. Ko W.C., Chuang Y.C., Huang G.C., Hsu S.Y. Infections due to non-O1 Vibrio cholerae in southern Taiwan: predominance in cirrhotic patients. Clin Infect Dis. 27:1998;774-780.
68. Benenson A.S., Islam M.R., Greenough WB, III. Rapid identification of Vibrio cholerae by dark-field microscopy. Bull World Health Organ. 30:1964;827-831.
69. Qadri F., Hasan J.A., Hossain J., et al. Evaluation of the monoclonal antibody-based kit Bengal SMART for rapid detection of Vibrio cholerae O139 synonym Bengal in stool samples. J Clin Microbiol. 33:1995;732-734.
70. Hasan J.A., Huq A., Tamplin M.L., Siebeling R.J., Colwell R.R. A novel kit for rapid detection of Vibrio cholerae O1. J Clin Microbiol. 32:1994;249-252.
71. Chattopadhyay D.J., Sarkar B.L., Ansari M.Q., et al. New phage typing scheme for Vibrio cholerae O1 biotype El Tor strains. J Clin Microbiol. 31:1993;1579-1585.
72. Chakrabarti A.K., Ghosh A.N., Nair G.B., Niyogi S.K., Bhattacharya S.K., Sarkar B.L. Development and evaluation of a phage typing scheme for Vibrio cholerae O139. J Clin Microbiol. 38:2000;44-49.
73. Momen H., Salles C.A. Enzyme markers for Vibrio cholerae: identification of classical, El Tor and environmental strains. Trans R Soc Trop Med Hyg. 79:1985;773-776.
74. Cameron D.N., Khambaty F.M., Wachsmuth I.K., Tauxe R.V., Barrett T.J. Molecular characterization of Vibrio cholerae O1 strains by pulsed-field gel electrophoresis. J Clin Microbiol. 32:1994;1685-1690.
75. Salles C.A., Momen H. Identification of Vibrio cholerae by enzyme electrophoresis. Trans R Soc Trop Med Hyg. 85:1991;544-547.
76. Chen F., Evins G.M., Cook W.L., Almeida R., Hargrett-Bean N., Wachsmuth K. Genetic diversity among toxigenic and nontoxigenic Vibrio cholerae O1 isolated from the Western Hemisphere. Epidemiol Infect. 107:1991;225-233.
77. Wachsmuth I.K., Evins G.M., Fields P.I., et al. The molecular epidemiology of cholera in Latin America. J Infect Dis. 167:1993;621-626.
78. Popovic T., Bopp C., Olsvik O., Wachsmuth K. Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1. J Clin Microbiol. 31:1993;2474-2482.
79. Faruque S.M., Saha M.N., Asadulghani, et al. The O139 serogroup of Vibrio cholerae comprises diverse clones of epidemic and nonepidemic strains derived from multiple V cholerae O1 or non-O1 progenitors. J Infect Dis. 182:2000;1161-1168.
80. Faruque S.M., Roy S.K., Alim A.R., Siddique A.K., Albert M.J. Molecular epidemiology of toxigenic Vibrio cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns. J Clin Microbiol. 33:1995;2833-2838.
81. Faruque S.M., Ahmed K.M., Abdul Alim A.R., Qadri F., Siddique A.K., Albert M.J. Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V cholerae O139 Bengal in Bangladesh. J Clin Microbiol. 35:1997;624-630.
82. Taylor R.K., Miller V.L., Furlong D.B., Mekalanos J.J. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci USA. 84:1987;2833-2837.
83. Sprinz H., Sribhibhadh R., Gangarosa E.J., Benyajati C., Kundel D., Halstead S. Biopsy of small bowel of Thai people with special reference to recovery from Asiatic cholera and to an intestinal malabsorption syndrome. Am J Clin Pathol. 38:1962;43-51.
84. De S.N. Enterotoxigenicity of bacteria free culture filtrate of Vibrio cholerae. Nature. 183:1959;1533.
85. Dutta N.K., Panse M.W., Kulkrni D.R. Role of cholera toxin in experimental cholera. J Bacteriol. 78:1959;594-595.
86. Finkelstein R.A., LoSpalluto J.J. Pathogenesis of experimental cholera: preparation and isolation of choleragen and choleragenoid. J Exp Med. 130:1969;185-202.
87. Holmgren J., Lonnroth I., Ouchterlony O. Identification and characterization of cholera exotoxin in culture filtrates of V cholerae. Acta Pathol Microbiol Scand [B] Microbiol Immunol. 79:1971;448.
88. Gill D.M. The arrangement of subunits in cholera toxin. Biochemistry. 15:1976;1242-1248.
89. Lonnroth I., Holmgren J. Subunit structure of cholera toxin. J Gen Microbiol. 76:1973;417-427.
90. Holmgren J., Lonnroth I., Svennerholm L. Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis. 5:1973;77-78.
91. Van Heyningen W.E., Carpenter C.C., Pierce N.F., Greenough WB III. Deactivation of cholera toxin by ganglioside. J Infect Dis. 124:1971;415-418.
92. Field M., Fromm D., Al Awqati Q., Greenough WB III. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest. 51:1972;796-804.
93. Speelman P., Butler T., Kabir I., Ali A., Banwell J. Colonic dysfunction during cholera infection. Gastroenterology. 91:1986;1164-1170.
94. Waldor M.K., Mekalanos J.J. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 272:1996;1910-1914.
95. Fasano A., Baudry B., Pumplin D.W., et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA. 88:1991;5242-5246.
96. Trucksis M., Conn T.L., Wasserman S.S., Sears C.L. Vibrio cholerae ACE stimulates Ca(2+)-dependent Cl(-)/HCO(3)(-) secretion in T84 cells in vitro. Am J Physiol Cell Physiol. 279:2000;C567-C577.
97. Waldor M.K., Rubin E.J., Pearson G.D., Kimsey H., Mekalanos J.J. Regulation, replication, and integration functions of the Vibrio cholerae CTXphi are encoded by region RS2. Mol Microbiol. 24:1997;917-926.
98. Faruque S.M., Asadulghani, Alim A.R., Albert M.J., Islam K.M., Mekalanos J.J. Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139. Infect Immun. 66:1998;3752-3757.
99. Reidl J., Klose K.E. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev. 26:2002;125-139.
100. Kirn T.J., Lafferty M.J., Sandoe C.M., Taylor R.K. Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae. Mol Microbiol. 35:2000;896-910.
101. Karaolis D.K., Johnson J.A., Bailey C.C., Boedeker E.C., Kaper J.B., Reeves P.R. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci USA. 95:1998;3134-3139.
102. Kovach M.E., Shaffer M.D., Peterson K.M. A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae. Microbiology. 142:1996;2165-2174.
103. Karaolis D.K., Somara S., Maneval D.R. Jr, Johnson J.A., Kaper J.B. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature. 399:1999;375-379.
104. Manning P.A. The tcp gene cluster of Vibrio cholerae. Gene. 192:1997;63-70.
105. Franzon V.L., Barker A., Manning P.A. Nucleotide sequence encoding the mannose-fucose-resistant hemagglutinin of Vibrio cholerae O1 and construction of a mutant. Infect Immun. 61:1993;3032-3037.
106. Jonson G., Lebens M., Holmgren J. Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes. Mol Microbiol. 13:1994;109-118.
107. Sengupta D.K., Sengupta T.K., Ghose A.C. Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization. Infect Immun. 60:1992;4848-4855.
108. Chiavelli D.A., Marsh J.W., Taylor R.K. The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol. 67:2001;3220-3225.
109. Heidelberg J.F., Eisen J.A., Nelson W.C., et al. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature. 406:2000;477-483.
110. Trucksis M., Michalski J., Deng Y.K., Kaper J.B. The Vibrio cholerae genome contains two unique circular chromosomes. Proc Natl Acad Sci USA. 95:1998;14464-14469.
111. Hughes K.J., Everiss K.D., Harkey C.W., Peterson K.M. Identification of a Vibrio cholerae ToxR-activated gene (tagD) that is physically linked to the toxin-coregulated pilus (tcp) gene cluster. Gene. 148:1994;97-100.
112. Parsot C., Taxman E., Mekalanos J.J. ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae. Proc Natl Acad Sci USA. 88:1991;1641-1645.
113. Peterson K.M., Mekalanos J.J. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect Immun. 56:1988;2822-2829.
114. Skorupski K., Taylor R.K. Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli. Mol Microbiol. 25:1997;1003-1009.
115. Parsot C., Mekalanos J.J. Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response. Proc Natl Acad Sci USA. 87:1990;9898-9902.
116. Stroeher U.H., Jedani K.E., Dredge B.K., et al. Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139. Proc Natl Acad Sci USA. 92:1995;10374-10378.
117. Bik E.M., Bunschoten A.E., Gouw R.D., Mooi F.R. Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 14:1995;209-216.
118. Comstock L.E., Johnson J.A., Michalski J.M., Morris J.G. Jr, Kaper J.B. Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol. 19:1996;815-826.
119. Yamasaki S., Shimizu T., Hoshino K., et al. The genes responsible for O-antigen synthesis of Vibrio cholerae O139 are closely related to those of Vibrio cholerae O22. Gene. 237:1999;321-332.
120. Dumontier S., Berche P. Vibrio cholerae O22 might be a putative source of exogenous DNA resulting in the emergence of the new strain of Vibrio cholerae O139. FEMS Microbiol Lett. 164:1998;91-98.
121. Berche P., Poyart C., Abachin E., et al. The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis. 170:1994;701-704.
122. Johnson J.A., Salles C.A., Panigrahi P., et al. Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun. 62:1994;2108-2110.
123. Waldor M.K., Mekalanos J.J. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J Infect Dis. 170:1994;278-283.
124. Comstock L.E., Maneval D. Jr, Panigrahi P., et al. The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun. 63:1995;317-323.
125. Colwell R.R., Kaper J., Joseph S.W. Vibrio cholerae, Vibrio parahaemolyticus, and other vibrios: occurrence and distribution in Chesapeake Bay. Science. 198:1977;394-396.
126. Nair G.B., Oku Y., Takeda Y., et al. Toxin profiles of Vibrio cholerae non-O1 from environmental sources in Calcutta, India. Appl Environ Microbiol. 54:1988;3180-3182.
127. Huq A., Small E.B., West P.A., Huq M.I., Rahman R., Colwell R.R. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol. 45:1983;275-283.
128. Islam M.S., Drasar B.S., Bradley D.J. Long-term persistence of toxigenic Vibrio cholerae 01 in the mucilaginous sheath of a blue-green alga, Anabaena variabilis. J Trop Med Hyg. 93:1990;133-139.
129. Colwell R.R. Global climate and infectious disease: the cholera paradigm. Science. 274:1996;2025-2031.
130. McCarthy S.A., Khambaty F.M. International dissemination of epidemic Vibrio cholerae by cargo ship ballast and other nonpotable waters. Appl Environ Microbiol. 60:1994;2597-2601.
131. Islam M.S., Drasar B.S., Sack R.B. Probable role of blue-green algae in maintaining endemicity and seasonality of cholera in Bangladesh: a hypothesis. J Diarrhoeal Dis Res. 12:1994;245-256.
132. Broza M., Halpern M. Pathogen reservoirs: chironomid egg masses and Vibrio cholerae. Nature. 412:2001;40.
133. Watnick P.I., Lauriano C.M., Klose K.E., Croal L., Kolter R. The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Mol Microbiol. 39:2001;223-235.
134. Colwell R.R. Viable but nonculturable bacteria: a survival strategy. J Infect Chemother. 6:2000;121-125.
135. Faruque S.M., Asadulghani, Saha M.N., et al. Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTXPhi: molecular basis for origination of new strains with epidemic potential. Infect Immun. 66:1998;5819-5825.
136. Mekalanos J.J., Rubin E.J., Waldor M.K. Cholera: molecular basis for emergence and pathogenesis. FEMS Immunol Med Microbiol. 18:1997;241-248.
137. Lazar S., Waldor M.K. ToxR-independent expression of cholera toxin from the replicative form of CTXphi. Infect Immun. 66:1998;394-397.
138. Mosley W.H., Aziz K.M., Mizanur Rahman A.S., et al. Report of the 1966-67 cholera vaccine trial in rural East Pakistan. Bull World Health Organ. 47:1972;229-238.
139. Holmgren J., Clemens J., Sack D.A., Svennerholm A.M. New cholera vaccines. Vaccine. 7:1989;94-96.
140. Tacket C.O., Cohen M.B., Wasserman S.S., et al. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infect Immun. 67:1999;6341-6345.
141. Clemens J.D., Sack D.A., Harris J.R., et al. Field trial of oral cholera vaccines in Bangladesh. Lancet. 2:1986;124-127.
142. Sanchez J.L., Vasquez B., Begue R.E., et al. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet. 344:1994;1273-1276.
143. Legros D., Paquet C., Perea W., et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 77:1999;837-842.
144. Levine M.M., Kaper J.B., Herrington D., et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet. 2:1988;467-470.
145. Richie E.E., Punjabi N.H., Sidharta Y.Y., et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine. 18:2000;2399-2410.
146. Tacket C.O., Kotloff K.L., Losonsky G., et al. Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. Am J Trop Med Hyg. 56:1997;533-537.
147. Sack D.A., Sack R.B., Shimko J., et al. Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers. J Infect Dis. 176:1997;201-205.
148. Cohen M.B., Giannella R.A., Bean J., et al. Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine. Infect Immun. 70:2002;1965-1970.
149. Trach D.D., Clemens J.D., Ke N.T., et al. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet. 349:1997;231-235.
150. Tacket C.O., Losonsky G., Nataro J.P., et al. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: a safety and efficacy against experimental challenge. J Infect Dis. 172:1995;883-886.